B. Lell

S. Agnandji, B. Lell, Boris K. Makanga, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Clinical and laboratory features of tuberculosis within a hospital population in Libreville, Gabon

B. Lell, M. Grobusch, D. Kombila, 2013, Infection.

Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial

S. Hoffman, B. Lell, A. Adegnika, 2022, Malaria journal.

Artesunate – amodiaquine combination therapy for falciparum malaria in young Gabonese children

B. Lell, P. Kremsner, M. Grobusch, 2007, Malaria Journal.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

M. Altfeld, S. Yerly, M. Addo, 2016, The New England journal of medicine.

Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections

S. Agnandji, B. Lell, J. Yasuda, 2020, BMC Infectious Diseases.

Clonal structure of Staphylococcus aureus colonizing children with sickle cell anaemia and healthy controls

A. Mellmann, B. Lell, A. Adegnika, 2012, Epidemiology and Infection.

Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial

S. Agnandji, B. Lell, A. Adegnika, 2019, Malaria Journal.

Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon.

B. Cissé, B. Lell, B. Mordmüller, 2008, The Journal of infectious diseases.

Willingness to Know the Cause of Death and Hypothetical Acceptability of the Minimally Invasive Autopsy in Six Diverse African and Asian Settings: A Mixed Methods Socio-Behavioural Study

Q. Bassat, C. Menéndez, J. Ordi, 2016, PLoS medicine.

Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children.

B. Lell, P. Kremsner, M. Missinou, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection

B. Lell, S. Issifou, P. Kremsner, 2011, Malaria Journal.

Delays in the arrival of the waves of COVID-19: a comparison between Gabon and the African continent

B. Lell, A. Adegnika, J. Yasuda, 2022, The Lancet Microbe.

Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambaréné, Gabon.

M. Alpers, B. Lell, P. Kremsner, 1999, The American journal of tropical medicine and hygiene.

Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D

M. Demoitié, S. Agnandji, B. Lell, 2011, PloS one.

TNFalpha-308A associated with shorter intervals of Plasmodium falciparum reinfections.

B. Lell, P. Kremsner, J. May, 2002, Tissue antigens.

Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications.

B. Lell, J. May, C. Meyer, 2000, The Journal of infectious diseases.

New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria.

B. Lell, P. Kremsner, J. Kun, 2002, The American journal of tropical medicine and hygiene.

A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon

K. Dietz, B. Lell, P. Kremsner, 2011, Malaria Journal.

Malaria chemoprophylaxis with tafenoquine: a randomised study

B. Lell, P. Kremsner, S. Borrmann, 2000, The Lancet.

Carriage of encapsulated bacteria in Gabonese children with sickle cell anaemia.

B. Lell, A. Adegnika, P. Kremsner, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Molecular characterization of Shigella spp. from patients in Gabon 2011-2013.

A. Mellmann, B. Lell, P. Kremsner, 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon

P. Hotez, B. Lell, A. Adegnika, 2022, PloS one.

Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative

S. Agnandji, B. Lell, J. Fernandes, 2018, BMJ Open.

Impact of Helminth Infections during Pregnancy on Vaccine Immunogenicity in Gabonese Infants

S. Agnandji, B. Lell, A. Adegnika, 2020, Vaccines.

Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2

B. Lell, A. Adegnika, B. Mordmüller, 2019 .

Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2.

S. Hoffman, B. Lell, J. Fernandes, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis?

B. Lell, S. Issifou, P. Kremsner, 2009, The Journal of infectious diseases.

Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria

B. Lell, B. Mordmüller, P. Kremsner, 1998, The Lancet.

A longitudinal study of allergy and intestinal helminth infections in semi urban and rural areas of Flores, Indonesia (ImmunoSPIN Study)

R. Van Ree, H. Uh, B. Lell, 2011, BMC Infectious Diseases.

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.

Trevor Bedford, Kevin Marsh, Elizabeth M. Ryan, 2015, The New England journal of medicine.

Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon

S. Hoffman, B. Lell, A. Adegnika, 2022, Scientific Reports.

Buruli Ulcer in Gabon, 2001–2010

B. Lell, A. Adegnika, B. Louis, 2012, Emerging infectious diseases.

A randomized controlled trial comparing the effectiveness of individual versus household treatment for Scabies in Lambaréné, Gabon

B. Lell, A. Adegnika, M. Ramharter, 2020, PLoS neglected tropical diseases.

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Pedro Alonso, Trudie Lang, Bernhards Ogutu, 2011, The New England journal of medicine.

Change in Plasmodium falciparum genotype during successive malaria episodes in Gabonese children

B. Lell, P. Kremsner, J. Kun, 2001, Parasitology Research.

COVID-19 in Africa: Dampening the storm?

B. Cissé, B. Lell, M. Mbow, 2020, Science.

Recombinase Polymerase Amplification and Lateral Flow Assay for Ultrasensitive Detection of Low-Density Plasmodium falciparum Infection from Controlled Human Malaria Infection Studies and Naturally Acquired Infections

S. Hoffman, S. Agnandji, B. Lell, 2020, Journal of Clinical Microbiology.

The potential effect of the African population age structure on COVID-19 mortality

B. Lell, F. Mougeni, A. Mangaboula, 2020, medRxiv.

Pentoxifylline as an adjunct therapy in children with cerebral malaria

D. Wypij, T. Taylor, B. Lell, 2010, Malaria Journal.

High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children

B. Lell, S. Issifou, P. Kremsner, 2011, Malaria Journal.

Identification of novel orthonairoviruses from rodents and shrews in Gabon, Central Africa.

B. Lell, R. Hewson, K. Yoshii, 2022, The Journal of general virology.

Novel orthonairovirus in rodents and shrews, Gabon

B. Lell, R. Hewson, Boris K. Makanga, 2022, bioRxiv.

Decrease of Stimulated Amylin Release Precedes Impairment of Insulin Secretion in Type II Diabetes

B. Ludvik, R. Prager, B. Lell, 1991, Diabetes.

Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus

B. Ludvik, R. Prager, B. Lell, 1990, The Lancet.

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.

A. Sié, B. Lell, B. Mordmüller, 2015, The Lancet. Infectious diseases.

Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children.

B. Lell, P. Kremsner, R. Schmidt-Ott, 1999, The Journal of infectious diseases.

Effect of antipyretic drugs in children with malaria.

B. Lell, W. Graninger, D. Luckner, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.

S. Hoffman, S. Agnandji, B. Lell, 2020, Vaccine.

Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon

S. Hoffman, B. Lell, A. Adegnika, 2017, The American journal of tropical medicine and hygiene.

Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria

B. Lell, P. Kremsner, R. Schmidt-Ott, 2000, Infection and Immunity.

The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel

S. Agnandji, B. Lell, J. Fernandes, 2011, Malaria Journal.

Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria

B. Lell, S. Issifou, P. Kremsner, 2008, Malaria Journal.

The circadian rhythm of body temperature is preserved during malarial fever.

B. Lell, W. Graninger, C. Brandts, 2000, Wiener klinische Wochenschrift.

Socio-economic status is inversely related to bed net use in Gabon

B. Lell, S. Issifou, P. Kremsner, 2008, Malaria Journal.

Urinary Metabolic Profiling in Volunteers Undergoing Malaria Challenge in Gabon

B. Everts, B. Lell, A. Adegnika, 2022, Metabolites.

Haematological and biochemical reference intervals for infants and children in Gabon

B. Lell, B. Mordmüller, P. Kremsner, 2011, Tropical medicine & international health : TM & IH.

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.

B. Lell, P. Kremsner, S. Borrmann, 2001, The Journal of infectious diseases.

For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

F. Cobelens, B. Lell, P. Kremsner, 2022 .

Malarial anaemia in African children associated with high oxygen-radical production

B. Lell, B. Greve, D. Luckner, 2000, The Lancet.

Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severity

B. Lell, P. Kremsner, M. Grobusch, 2008, Malaria Journal.

Assessment of a simplified method for counting leukocytic malaria pigment.

T. Taylor, B. Lell, S. Issifou, 2005, The American journal of tropical medicine and hygiene.

A blinded, controlled trial of an ultrasound device as mosquito repellent.

B. Lell, P. Kremsner, K. Sylla el-H, 2000, Wiener klinische Wochenschrift.

Clinical and parasitological characteristics of puerperal malaria.

S. Agnandji, B. Lell, A. Adegnika, 2005, The Journal of infectious diseases.

Virulence factors and genotypes of Staphylococcus aureus from infection and carriage in Gabon.

A. Mellmann, B. Lell, A. Adegnika, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The Effect of Three-Monthly Albendazole Treatment on Malarial Parasitemia and Allergy: A Household-Based Cluster-Randomized, Double-Blind, Placebo-Controlled Trial

R. Tsonaka, J. Houwing-Duistermaat, R. Van Ree, 2013, PloS one.

A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children.

S. Agnandji, B. Lell, J. Fernandes, 2016, Vaccine.

Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013

A. van der Ende, C. Visser, B. Lell, 2015, Emerging infectious diseases.

Fosmidomycin, a Novel Chemotherapeutic Agent for Malaria

Jochen Wiesner, J. Wiesner, H. Jomaa, 2003, Antimicrobial Agents and Chemotherapy.

Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children

B. Lell, P. Kremsner, D. Luckner, 1998, The Lancet.

Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.

B. Lell, P. Kremsner, J. Faucher, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Effect of Ozone on Plasmodium Falciparum-Infected Red Blood Cells

B. Lell, P. Kremsner, R. Viebahn-hänsler, 2015 .

The Activity of Ozone Against Plasmodium Falciparum

B. Lell, P. Kremsner, R. Viebahn, 2001 .

Ongoing evolution of hepatitis B virus during viremia in patients with febrile in Central Africa

S. Agnandji, B. Lell, M. Grobusch, 2020, Journal of medical virology.

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine

Kwaku Poku Asante, K. Bojang, A. Ghani, 2014, BMC Medicine.

Low-Dose Treatment with Sulfadoxine-Pyrimethamine Combinations Selects for Drug-Resistant Plasmodium falciparum Strains

B. Lell, P. Kremsner, R. Schmidt-Ott, 1999, Antimicrobial Agents and Chemotherapy.

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials

Pedro Alonso, Marcel Tanner, David Schellenberg, 2009, The Lancet.

Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.

S. Agnandji, B. Lell, S. Issifou, 2007, The Journal of infectious diseases.

Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon.

B. Lell, P. Kremsner, S. Krishna, 2005, The Journal of infectious diseases.

Pfmdr1 Alleles and Response to Ultralow-Dose Mefloquine Treatment in Gabonese Patients

B. Lell, P. Kremsner, F. Ntoumi, 2002, Antimicrobial Agents and Chemotherapy.

The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data

B. Lell, Bertrand Lell, 2013, PLoS medicine.

Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2

S. Hoffman, S. Agnandji, B. Lell, 2021, PLoS neglected tropical diseases.

Epidemiology of Schistosomiasis and Soil-Transmitted Helminth Coinfections among Schoolchildren Living in Lambaréné, Gabon.

S. Agnandji, B. Lell, A. Adegnika, 2020, The American journal of tropical medicine and hygiene.

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon

B. Lell, A. Adegnika, B. Mordmüller, 2019, Parasites & Vectors.

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon

B. Lell, A. Adegnika, B. Mordmüller, 2019, Parasites & Vectors.

Schistosoma haematobium effects on Plasmodium falciparum infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon

S. Agnandji, B. Lell, A. Adegnika, 2018, PLoS neglected tropical diseases.

Assessment of the effect of Schistosoma haematobium co infection on malaria parasites and immune responses in rural populations in Gabon: study protocol

B. Lell, A. Adegnika, P. Kremsner, 2014, SpringerPlus.

Pharmacokinetics of Ferroquine, a Novel 4-Aminoquinoline, in Asymptomatic Carriers of Plasmodium falciparum Infections

C. Biot, B. Lell, S. Issifou, 2012, Antimicrobial Agents and Chemotherapy.

Immunoglobulin G Isotype Responses to Variant Surface Antigens of Plasmodium falciparum in Healthy Gabonese Adults and Children during and after Successive Malaria Attacks

B. Lell, P. Kremsner, A. Tebo, 2004, Infection and Immunity.

Association of low birth weight and polyparasitic infection during pregnancy in Lambaréné, Gabon

B. Lell, A. Adegnika, P. Kremsner, 2021, Tropical medicine & international health : TM & IH.

Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy

S. Agnandji, B. Lell, A. Adegnika, 2021, PLoS neglected tropical diseases.

Demography, maternal health and the epidemiology of malaria and other major infectious diseases in the rural department Tsamba-Magotsi, Ngounie Province, in central African Gabon

S. Agnandji, B. Lell, B. Mordmüller, 2017, BMC Public Health.

Evaluation of the safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project)

C. Menéndez, B. Lell, J. Mischlinger, 2021, BMJ Open.

DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon

S. Agnandji, B. Lell, A. Adegnika, 2019, Malaria Journal.

Preliminary Evidence for the Absence of Cystic Echinococcosis in Gabon: A Cross-Sectional Pilot Survey in Humans and Definitive Hosts.

S. Agnandji, B. Lell, A. Adegnika, 2018, The American journal of tropical medicine and hygiene.

Efficacy and Safety of Fosmidomycin–Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon

B. Lell, A. Adegnika, B. Mordmüller, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups

B. Lell, A. Adegnika, P. Kremsner, 2013, Malaria Journal.

A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial

C. Karema, Q. Bassat, P. Williamson, 2011 .

History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon

S. Agnandji, B. Lell, A. Adegnika, 2007, Wiener klinische Wochenschrift.

Short-Course Artesunate Treatment of Uncomplicated Plasmodium falciparum Malaria in Gabon

B. Lell, A. Adegnika, S. Issifou, 2003, Antimicrobial Agents and Chemotherapy.

Randomized, Controlled, Assessor-Blind Clinical Trial To Assess the Efficacy of Single- versus Repeated-Dose Albendazole To Treat Ascaris lumbricoides, Trichuris trichiura, and Hookworm Infection

S. Agnandji, B. Lell, A. Adegnika, 2014, Antimicrobial Agents and Chemotherapy.

Atopy and malaria.

B. Lell, M. Yazdanbakhsh, S. Borrmann, 2001, Wiener klinische Wochenschrift.

Short Report: Impact of Short-Time Urine Freezing on the Sensitivity of an Established Schistosoma Real-Time PCR Assay

B. Lell, A. Adegnika, J. Verweij, 2014 .

High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria.

B. Lell, P. Kremsner, R. Schmidt-Ott, 1999, The Journal of infectious diseases.

Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria.

I. D. de Messias-Reason, B. Lell, P. Kremsner, 2011, Human immunology.

Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries

Kwaku Poku Asante, M. Tanner, C. Drakeley, 2017, Malaria Journal.

Limit of blank and limit of detection of Plasmodium falciparum thick blood smear microscopy in a routine setting in Central Africa

B. Lell, B. Mordmüller, T. Engleitner, 2014, Malaria Journal.

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.

Kwaku Poku Asante, M. Tanner, S. Agnandji, 2011, The Lancet. Infectious diseases.

Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study

B. Lell, A. Adegnika, P. Kremsner, 2022, PLoS neglected tropical diseases.

Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups

B. Lell, A. Adegnika, P. Kremsner, 2013, Malaria Journal.

Epidemiology of dengue fever in Gabon: Results from a health facility-based fever surveillance in Lambaréné and its surroundings.

S. Agnandji, B. Lell, J. Fernandes, 2021, PLoS neglected tropical diseases.

Validity and reliability of methods to microscopically detect and quantify malaria parasitaemia

B. Lell, A. Adegnika, B. Mordmüller, 2018, Tropical medicine & international health : TM & IH.

Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings.

B. Lell, A. Adegnika, P. Kremsner, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Urogenital schistosomiasis during pregnancy is associated with low birth weight delivery: analysis of a prospective cohort of pregnant women and their offspring in Gabon.

C. Menéndez, S. Agnandji, B. Lell, 2017, International journal for parasitology.

Urogenital schistosomiasis during pregnancy is associated with low birth weight delivery: Analysis of a prospective cohort of pregnant women in Gabon

C. Menéndez, S. Agnandji, B. Lell, 2016 .

Medical research at the Albert Schweitzer Hospital.

B. Lell, A. Adegnika, S. Issifou, 2010, Wiener klinische Wochenschrift.

Randomized Controlled Trial of Fosmidomycin-Clindamycin versus Sulfadoxine-Pyrimethamine in the Treatment of Plasmodium falciparum Malaria

B. Lell, S. Issifou, P. Kremsner, 2007, Antimicrobial Agents and Chemotherapy.

DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria.

B. Lell, P. Kremsner, R. Vonthein, 2004, The Journal of infectious diseases.

Fosmidomycin for malaria

Jochen Wiesner, J. Wiesner, H. Jomaa, 2002, The Lancet.

Pyruvate Kinase and Fc&ggr; Receptor Gene Copy Numbers Associated With Malaria Phenotypes

B. Lell, P. Kremsner, T. Velavan, 2017, The Journal of infectious diseases.

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

M. Kieny, S. Agnandji, B. Lell, 2017, PLoS medicine.

The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants

Kwaku Poku Asante, M. Tanner, S. Agnandji, 2015, Malaria Journal.

Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children.

B. Lell, S. Issifou, P. Kremsner, 2005, The Journal of infectious diseases.

NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity

K. Berger, B. Lell, P. Kremsner, 2008, Malaria Journal.

Re-emergence of dengue virus serotype-3 infections in Gabon in 2016-2017, and evidence for the risk of repeated dengue virus infections.

S. Agnandji, B. Lell, M. Grobusch, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon

S. Agnandji, B. Lell, A. Adegnika, 2022, Infection.

Long-term validation of a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 from March 2020 to October 2021 in Central Africa, Gabon

B. Lell, A. Adegnika, J. Yasuda, 2022, PLoS neglected tropical diseases.

Unrecognized introduction of SARS‐CoV‐2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent

B. Lell, A. Adegnika, J. Yasuda, 2021, Journal of medical virology.

First evidence for continuous circulation of hepatitis A virus subgenotype IIA in Central Africa

S. Agnandji, B. Lell, M. Grobusch, 2020, Journal of viral hepatitis.

Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression

S. Hoffman, B. Lell, B. Mordmüller, 2019, PLoS pathogens.

HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections.

B. Lell, J. May, C. Meyer, 2001, The Journal of infectious diseases.

HLA class II factors associated with Plasmodium falciparum merozoite surface antigen allele families.

B. Lell, P. Kremsner, J. May, 1999, The Journal of infectious diseases.

Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.

B. Lell, S. Issifou, P. Kremsner, 2008, The Journal of infectious diseases.

Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon.

L. H. Taylor, B. Lell, P. Kremsner, 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Plasmodium falciparum: in vitro growth inhibition by febrile temperatures

K. Dietz, B. Lell, P. Kremsner, 2001, Parasitology Research.

Malaria and money

B. Lell, 2004, Wiener Klinische Wochenschrift.

Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children.

B. Lell, P. Kremsner, S. Borrmann, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections.

B. Lell, P. Kremsner, S. Borrmann, 2002, The Journal of antimicrobial chemotherapy.

The effect of dose on the antimalarial efficacy of artemether – lumefantrine : a systematic review and pooled analysis of individual patient data Worldwide Antimalarial Resistance Network ( WWARN ) AL Dose Impact Study Group

S. Abdulla, P. Gething, O. Doumbo, 2015 .

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

Kwaku Poku Asante, M. Tanner, S. Adjei, 2019, Vaccine.

Placental malaria increases malaria risk in the first 30 months of life.

S. Agnandji, B. Lell, A. Adegnika, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasis.

B. Lell, A. Adegnika, S. Issifou, 2012, Genetic testing and molecular biomarkers.

Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa.

B. Lell, J. Fernandes, A. Adegnika, 2012, Acta tropica.

Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data

Georgina S. Humphreys, O. Müller, R. Price, 2022, BMC Medicine.

Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.

Kwaku Poku Asante, M. Tanner, M. Demoitié, 2010, The Journal of infectious diseases.

Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon.

B. Lell, P. Kremsner, R. Schmidt-Ott, 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Promoter variants of the human mannose-binding lectin gene show different binding.

B. Lell, P. Kremsner, J. May, 2000, Biochemical and biophysical research communications.

Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes

M. Petzl-Erler, K. Dietz, F. Lang, 2010, BMC Genetics.

Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambaréné, Gabon.

B. Lell, S. Issifou, P. Kremsner, 2009, Vaccine.

A randomized controlled trial comparing the effectiveness of individual versus household treatment for Scabies in Lambaréné, Gabon

B. Lell, A. Adegnika, M. Ramharter, 2019, PLoS neglected tropical diseases.

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Kwaku Poku Asante, M. Tanner, S. Adjei, 2019, Human vaccines & immunotherapeutics.

Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials.

Q. Bassat, S. Agnandji, B. Lell, 2015, Future microbiology.

Fosmidomycin as an Antimalarial Agent

J. Wiesner, H. Jomaa, A. Reichenberg, 2012 .

Assessment of LED fluorescence microscopy for the diagnosis of Plasmodium falciparum infections in Gabon

B. Lell, A. Adegnika, B. Mordmüller, 2011, Malaria Journal.

Plasmodium falciparum transmission intensity and infection rates in children in Gabon

B. Lell, J. Kun, P. Kremsner, 2001, Parasitology Research.

Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial

B. Lell, S. Issifou, P. Kremsner, 2008, Malaria Journal.

Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection

M. Pedroso, B. Lell, S. Issifou, 2009, Malaria Journal.

SARS-CoV-2 emerging variants in Africa: view from Gabon

B. Lell, A. Adegnika, J. Yasuda, 2021, The Lancet Microbe.

Re-emergence of dengue, chikungunya, and Zika viruses in 2021 after a 10-year gap in Gabon

S. Agnandji, B. Lell, J. Yasuda, 2022, IJID Regions.

Birth weight, growth, nutritional status and mortality of infants from Lambaréné and Fougamou in Gabon in their first year of life.

C. Menéndez, S. Agnandji, B. Lell, 2021, PloS one.

Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.

B. Lell, L. Lehman, P. Kremsner, 1998, The American journal of tropical medicine and hygiene.

Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central Africa

S. Niemann, B. Lell, A. Adegnika, 2022, Infection.

Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity

E. Eisemann, J. Goeman, S. Hoffman, 2021, Nature Immunology.

CONCISE Artesunate and Praziquantel for the Treatment of Schistosoma haematobium Infections: A Double-Blind, Randomized, Placebo-Controlled Study

B. Lell, P. Kremsner, S. Borrmann, 2001 .

Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field

B. Lell, A. Adegnika, M. Grobusch, 2019, Infection.

Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon

S. Agnandji, B. Lell, A. Adegnika, 2021, Wiener klinische Wochenschrift.

Cellular and humoral responses to tetanus vaccination in Gabonese children.

H. Uh, B. Lell, A. Adegnika, 2008, Vaccine.

Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon.

B. Lell, R. Schmidt-Ott, B. Greve, 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria.

B. Lell, P. Kremsner, B. Ogutu, 2017, The American journal of tropical medicine and hygiene.

No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection.

B. Lell, P. Kremsner, R. Schmidt-Ott, 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon

B. Lell, A. Adegnika, B. Mordmüller, 2021, Parasites & vectors.

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.

Ogobara K. Doumbo, Simon I. Hay, Peter W. Gething, 2015 .

Antibody responses to Plasmodium falciparum: evolution according to the severity of a prior clinical episode and association with subsequent reinfection.

B. Lell, R. Schmidt-Ott, S. Ulbert, 2000, The American journal of tropical medicine and hygiene.

Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial

S. Hoffman, B. Lell, A. Adegnika, 2022, Malaria journal.

Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon

Samira Zoa Assoumou, B. Lell, A. Adegnika, 2021, International Journal of Infectious Diseases.

Seroepidemiological Reconstruction of Long-term Chikungunya Virus Circulation in Burkina Faso and Gabon

S. Weaver, H. Salje, B. Lell, 2022, The Journal of infectious diseases.

A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon

M. Demoitié, S. Agnandji, B. Lell, 2009, PloS one.

Pharyngeal Communities and Antimicrobial Resistance in Pangolins in Gabon

A. Mellmann, B. Lell, A. Adegnika, 2023, Microbiology spectrum.

Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria.

B. Lell, P. Kremsner, R. Schmidt-Ott, 1999, European cytokine network.

Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.

B. Lell, H. Mennel, 2005, Clinical neuropathology.

Causes of fever in Gabonese children: a cross-sectional hospital-based study

S. Agnandji, B. Lell, J. Fernandes, 2020, Scientific Reports.

HHV-6 infections in hospitalized young children of Gabon

S. Agnandji, B. Lell, J. Fernandes, 2023, Infection.

Cost-effectiveness of intermittent preventive treatment of malaria in infants (IPTi) for averting anaemia in Gabon: a comparison between intention to treat and according to protocol analyses

C. Menéndez, L. Conteh, B. Lell, 2011, Malaria Journal.

Causes of fever in Gabonese children: a cross-sectional hospital-based study

S. Agnandji, B. Lell, J. Fernandes, 2020, Scientific Reports.

Effect of alcohol on growth of Plasmodium falciparum.

B. Lell, P. Kremsner, V. Q. Binh, 2000, Wiener Klinische Wochenschrift.

The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.

S. Abdulla, P. Gething, O. Doumbo, 2015, The Lancet. Infectious diseases.

Haematological and biochemical reference intervals for infants and children in Gabon

B. Lell, B. Mordmüller, P. Kremsner, 2011, Tropical medicine & international health : TM & IH.

The history of circadian rhythm research in Austria.

G. Klösch, I. Ellinger, B. Lell, 2023, Wiener klinische Wochenschrift.

UvA-DARE ( Digital Academic Repository ) A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon

K. Dietz, B. Lell, P. Kremsner, 2017 .

Genetic Diversity of Hepatitis B and C Viruses Revealed by Continuous Surveillance from 2015 to 2021 in Gabon, Central Africa

B. Lell, J. Yasuda, Y. Ushijima, 2023, Microorganisms.

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

F. Cobelens, B. Lell, P. Kremsner, 2002, The Lancet.

Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.

S. Agnandji, B. Lell, S. Issifou, 2007, The Journal of infectious diseases.

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Kwaku Poku Asante, R. Verity, A. Ghani, 2015, The Lancet. Infectious diseases.

Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes

M. Petzl-Erler, K. Dietz, F. Lang, 2010, BMC Genetics.